Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "company"), a leading global eye health company dedicated to helping people see better to live better, today announced that it closed ...

Bausch + Lomb is taking out roughly $2.8 billion in new loans to refinance its debt. The eye health company, a subsidy of Bausch Health Cos., said Friday that it was amending its credit agreement to ...

Bausch + Lomb Corporation ( ($BLCO) ) has shared an update. On January 2, 2026, Bausch + Lomb Corporation closed a refinancing of its existing ...

VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today ...

CVS Pharmacy is suing one of its largest suppliers in federal court, accusing Bausch Health and generic giant Teva of keeping ...

According to Benzinga Pro, Bausch Health Companies Inc's peer group average for short interest as a percentage of float is 10.86%, which means the company has less short interest than most of its ...

The great German choreographer's landmark work, which was first presented in 1978 in Wuppertal, is revived on the main stage ...

In addition to the "Dry January" series, Recovery Demystified hosts potlucks and other gatherings, publishes a Substack at ...

The beauty devices market offers growth opportunities through the demand for multifunctional, at-home tech, regional adoption ...

The great German choreographer's landmark work, which was first presented in 1978 in Wuppertal, is revived on the main stage ...

Bausch Health Companies recently completed fixed-income exchange offers, issuing US$1.60 billion of new 10.00% Senior Secured Notes due 2032 to refinance existing senior secured notes under Regulation ...

Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% of their value on a report that a joint takeover bid for the group is in trouble. The Financial Times has said that ...